Metabolic disease definition

Metabolic disease means a disease as designated by rule of the state health council for which early identification and timely intervention will lead to a significant reduction in mortality, morbidity, and associated disabilities.
Sample 1Sample 2Sample 3
Metabolic disease means diabetes or metabolic syndrome.
Sample 1Sample 2Sample 3
Metabolic disease meansand "genetic disease" mean a disease as designated by rule of the state health council for which early identification and timely intervention will lead to a significant reduction in mortality, morbidity, and associated disabilities.
Sample 1Sample 2

Examples of Metabolic disease in a sentence

  • Metabolic disease and cardiovascular risk in people treated with antipsychotics in the community.

  • These codes were grouped by a medical expert into the following eight major disease categories:– Cardiovascular disease (CARDI).– Renal disease (RENAL).– Peripheral vascular disease (PERIP).– Neurological disease (NEURO).– Metabolic disease (METAB).– Inflammatory (infectious) disease (INFLM).– Ocular (ophthalmologic) disease (OCULR).– Cerebrovascular disease (CEREB).Our objective is to learn models that are able to accurately diagnose each of these major diseases.

  • Metabolic disease (e.g., DIABETES, thyrotoxicosis, or myxedema) ( ) ( ) 15.

  • This is why the areas where the infection is endemic, such as Asia, are the most affected by HCC;- Consumption of large amounts of alcohol, because of its implication in cirrhosis, is also an HCC risk factor which contributes more extensively in Western than in Asian countries;- Metabolic disease, and in particular obesity, are a growing cause of cirrhosis and HCC.Most HCCs are diagnosed at an advanced stage because the tumor progresses without any visible clinical manifestations in the early stages.

  • Reported Underlying Health Conditions among Child and Adolescent COVID-19 Hospitalizations175-17 years0-4 years020406080100120140160ObesityLung diseaseAsthmaNeurologic disorderImmunocompromised Feeding tube dependent Metabolic disease DiabetesCenters for Disease Control and Prevention, MMWR, August 7, 2020.

  • Additional information, including the company’s Annual Report and Annual Information Form, are available on the company’s Web site at www.brookfieldproperties.com or on SEDAR’s Web site at www.sedar.com.

  • Crunkhorn, Metabolic disease: New role for HDACs in glucose homeostasis.

  • This course is organised by a collaboration between the Department of Geriatrics and Metabolic disease, the Department of Clinical and Experimental Medicine and the Istituto di Clinica Odontoiatnca e Stomatologia with the involvement of academic physicians.

  • Metabolic disease was induced in two cohorts of mice ("Donors" and "Recipients") via consumption of a high fat, high cholesterol, high carbohydrate (HFHCC) diet for 10 weeks.

  • Metabolic disease drug discoveryd"hitting the target" is easier said than done.


More Definitions of Metabolic disease

Metabolic disease means diseases of metabolism, including, but not limited to, diabetes, obesity and Syndrome X, and excluding metabolic diseases of infectious pathogen origin or hosted by pathogen infection.
Sample 1
Metabolic disease means a disease as designated by rule of the state health
Sample 1

Related to Metabolic disease

  • inherited metabolic disease means a disease caused by an inherited abnormality of body chemistry for which testing is mandated by law;

  • Inherited Metabolic Disorder means a disease caused by an inherited abnormality of body chemistry that meets all of the following requirements:

  • Therapeutic diet means meals served that are soft, low-fat, low-sodium or controlled calorie.

  • Acute toxicity means concurrent and delayed adverse effects that result from an acute exposure and occur within any short observation period, which begins when the exposure begins, may extend beyond the exposure period, and usually does not constitute a substantial portion of the life span of the organism.

  • Pivotal Trial means a clinical study in humans of the efficacy and safety of a Licensed Product that is prospectively designed to demonstrate with statistical significance that such product is effective and safe for use in a particular indication in a manner sufficient to file for Marketing Approval of such product and would satisfy the requirements of 21 CFR 312.21(c), or a similar clinical study prescribed by the Regulatory Authorities in a country other than the United States.

  • Phase III Clinical Trial means a large, controlled or uncontrolled Clinical Study that would satisfy the requirements of 21 CFR 312.21(c), intended to gather the additional information about effectiveness and safety that is needed to evaluate the overall benefit-risk relationship of the drug and to provide an adequate basis for physician labeling.

  • Phase IIb Clinical Trial means a clinical trial of a Product on sufficient numbers of patients that is designed to provide a preliminary determination of safety and efficacy of such Product in the target patient population over a range of doses and dose regimens.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • Phase III Clinical Study means a trial involving administration of a Compound to sufficient numbers of human patients with the goal of establishing that the Compound is safe and efficacious for its intended use, to define warnings, precautions and adverse reactions that are associated with the drug or label expansion of such Compound, and to be considered as a pivotal study for submission of an NDA.

  • Opioid antagonist means a drug that binds to opioid

  • Biological Samples means any physical samples obtained from Study Participants in accordance with the Protocol for the purposes of the Study.

  • Pivotal Clinical Trial means a pivotal human clinical trial of a Licensed Product with a defined dose or a set of defined doses of such Licensed Product designed to ascertain efficacy and safety of such Licensed Product for the purpose of enabling the preparation and submission of an MAA to the competent Regulatory Authorities in a country of the Territory, as further defined in 21 C.F.R. § 312.21(c) for the U.S., as amended from time to time, or the corresponding foreign regulations.

  • Dose is a generic term that means absorbed dose, dose equivalent, effective dose equivalent, committed dose equivalent, committed effective dose equivalent, total organ dose equivalent, or total effective dose equivalent. For purposes of these regulations, "radiation dose" is an equivalent term.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Massive Multiauthor Collaboration Site (or “MMC Site”) means any World Wide Web server that publishes copyrightable works and also provides prominent facilities for anybody to edit those works. A public wiki that anybody can edit is an example of such a server. A “Massive Multiauthor Collaboration” (or “MMC”) contained in the site means any set of copyrightable works thus published on the MMC site.

  • Biological diversity means the variability among living organisms from all sources including, inter alia, terrestrial, marine and other aquatic ecosystems and the ecological complexes of which they are part; this includes diversity within species, between species and of ecosystems.

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid a quantity soluble lead compound exceeding, when calculated as lead monoxide, five percent of the dry weight of the portion taken analysis.

  • Phase II Clinical Trial means a controlled human clinical study that would satisfy the requirements of 21 CFR 312.21(b), conducted to study the effectiveness and establish the dose range of a Product for a particular Indication in patients with the disease or condition under study, including a Phase IIA Clinical Study or Phase IIB Clinical Study.

  • Anaerobic digestion ’ means a controlled process involving microbial decomposition of organic matter in the absence of oxygen ;

  • Cannabinoid means any of the chemical compounds that are the active constituents of marijuana.

  • Diagnostic Product means In Vitro Diagnostics, In Vivo Diagnostic Agents and any product used for Diagnosis.

  • Public display means the showing of the original or a copy of a work—

  • Vaccine means a specially prepared antigen which, upon administration to a person, will result in immunity and, specifically for the purposes of this rule, shall mean influenza and pneumococcal vaccines.

  • Phase III Study means a human clinical trial that is prospectively designed to demonstrate statistically whether a product is safe and effective for use in humans in a manner sufficient to obtain regulatory approval to market such product in patients having the disease or condition being studied as described in 21 C.F.R. § 312.21(c) (FDCA), as amended from time to time, and the foreign equivalent thereof.

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • Anabolic steroid means any drug or hormonal substance, chemically and pharmacologically related